2024
Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy
Verma N, Laird J, Moore N, Hayman T, Housri N, Peters G, Knowlton C, Jairam V, Campbell A, Park H. Radioresistant Pulmonary Oligometastatic and Oligoprogressive Lesions From Nonlung Primaries: Impact of Histology and Dose-Fractionation on Local Control After Radiation Therapy. Advances In Radiation Oncology 2024, 9: 101500. PMID: 38699671, PMCID: PMC11063223, DOI: 10.1016/j.adro.2024.101500.Peer-Reviewed Original ResearchLocal recurrence-free survivalNon-lung primaryAssociated with higher local recurrence-free survivalProgression-free survivalBiologically effective doseLocal controlRadioresistant metastasesOverall survivalPulmonary metastasesPrimary cancerColorectal carcinomaAssociated with superior local controlMultivariate analysisPatients treated with radiotherapyRisk of local recurrenceMedian follow-up timeMultivariable Cox proportional hazards regressionInferior local controlMedian total doseSuperior local controlAssociated with decreased riskImpact of histologyMetastasis-free survivalRecurrence-free survivalLocal failure
2009
Outcomes of Malignant CNS Ependymomas: An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973–2005)
Rodríguez D, Cheung MC, Housri N, Quinones-Hinojosa A, Camphausen K, Koniaris LG. Outcomes of Malignant CNS Ependymomas: An Examination of 2408 Cases Through the Surveillance, Epidemiology, and End Results (SEER) Database (1973–2005). Journal Of Surgical Research 2009, 156: 340-351. PMID: 19577759, PMCID: PMC7371344, DOI: 10.1016/j.jss.2009.04.024.Peer-Reviewed Original ResearchConceptsEnd Results (SEER) databaseSurgical resectionCNS ependymomasMedian survivalResults databaseRadiation therapyMultivariate analysisIntracranial tumor locationOverall median survivalRole of surgeryFive-year survivalSignificant survival benefitLonger median survivalGrade III tumorsPrimary tumor siteLack of radiationMedian agePatient ageSurvival benefitImproved survivalIndependent predictorsAnnual incidenceMalignant ependymomaSurgical extirpationPatient survivalSurgery does not adversely affect survival in primary gastrointestinal lymphoma
Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG. Surgery does not adversely affect survival in primary gastrointestinal lymphoma. Journal Of Surgical Oncology 2009, 100: 59-64. PMID: 19399785, DOI: 10.1002/jso.21298.Peer-Reviewed Original ResearchConceptsGastrointestinal lymphomaMultivariate analysisMarginal zone B-cell lymphomaAssociated survival benefitPrimary gastrointestinal lymphomaEnd Results (SEER) databaseImpact of surgeryRisk of deathB-cell lymphomaMedian survivalOverall survivalSurgical resectionIndependent predictorsSurvival benefitOverall incidencePoor prognosisResults databaseSurgical extirpationExtirpative surgeryTumor locationMale genderUnivariate analysisSurgeryLymphomaTreatment data
2008
Malignant abdominal mesothelioma: Defining the role of surgery
Rodríguez D, Cheung MC, Housri N, Koniaris LG. Malignant abdominal mesothelioma: Defining the role of surgery. Journal Of Surgical Oncology 2008, 99: 51-57. PMID: 18942074, DOI: 10.1002/jso.21167.Peer-Reviewed Original ResearchConceptsRole of surgerySurgical resectionMedian survivalDifferentiated tumor gradePotential surgical resectionOverall median survivalEnd Results (SEER) databaseLonger median survivalLocalized diseaseYounger patientsIndependent predictorsAnnual incidenceResults databasePoor outcomeSurgical extirpationMale genderMalignant mesotheliomaTumor gradeAdvanced ageAbdominal mesotheliomaPatientsMultivariate analysisResectionSurvivalSignificant differences